• 首页期刊简介编委会刊物订阅专栏专刊电子刊学术动态联系我们English
引用本文:方笑语,葛渊源.FDA已批准鼻用制剂的辅料分析及研究进展[J].中国现代应用药学,2023,40(20):2811-2817.
FANG Xiaoyu,GE Yuanyuan.Research Advances and Analysis of Excipients Used in Nasal Drugs New Approved by FDA[J].Chin J Mod Appl Pharm(中国现代应用药学),2023,40(20):2811-2817.
【打印本页】   【HTML】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 3100次   下载 2543 本文二维码信息
码上扫一扫!
分享到: 微信 更多
FDA已批准鼻用制剂的辅料分析及研究进展
方笑语, 葛渊源
上海药品审评核查中心, 上海 201210
摘要:
因鼻腔构造的特殊性,在鼻用制剂处方中加入功能性辅料,可起到改善药物活性物质的透膜吸收或减少鼻黏膜纤毛的清除作用,对维持药物活性物质在目标区域的有效浓度,促进鼻黏膜吸收起着重要作用。本文通过对美国食品药品监督管理局近十年已批准上市的鼻腔制剂新药中使用的辅料进行汇总分析,并结合鼻用辅料目前研究进展与安全性评价情况对其进行综述,为开发鼻用制剂在辅料选择上提供思路和借鉴。
关键词:  美国食品药品监督管理局  鼻用制剂  辅料  安全性评价
DOI:10.13748/j.cnki.issn1007-7693.20232012
分类号:
基金项目:
Research Advances and Analysis of Excipients Used in Nasal Drugs New Approved by FDA
FANG Xiaoyu, GE Yuanyuan
Shanghai Center for Drug Evaluation and Inspection, Shanghai 201210, China
Abstract:
Due to the special structure of the nasal cavity, the addition of functional excipients in nasal drugs can improve the transmembrane absorption of the active pharmaceutical ingredient or reduce the clearance of nasal mucocilia, which plays an important role in maintaining the effective concentration of active pharmaceutical ingredient in the target area and promoting the absorption of nasal mucosa. In this paper, the excipients used in drug new approved by the United States Food and Drug Administration(FDA) in the past decade were summarized, and the current research advances and safety evaluation of excipients for nasal drug were reviewed, providing ideas and references for the selection of excipients for nasal drug development.
Key words:  FDA  nasal drug  excipients  safety evaluation
扫一扫关注本刊微信